Cytodyn Inc at Lee Kelso discusses Leronlimab on WOWO radio Transcript
No, I asked Lee to come on today because he forwarded some information to me about leronlimab. When you say what, leronlimab, l-e-r-o-n-l-i-m-a-b, I'm not a scientist. I got on the Google, and I had Siri tell me how to say it.
Questions & Answers
But leronlimab or PRO 140. This is something that seems, Lee, at least at the outset, might be giving us some promising results. What is it? How far are they in looking at it? And does this give us some additional hope?
Yes, yes, and yes. So I reached out to you, Pat, because I study COVID, just it's ridiculous. The amount of time that I spend looking at things and I watched the presentation on this drug. It's a monoclonal antibody and it struck me because it is proving effective in people with renal failure and organ transplants who are [immunocompromised].
Exactly, so I was thinking of you and dropped you a little note that said, hey, you need to know about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |